Guru Ownership Trend
Guru Analysis for BridgeBio Pharma, Inc. (BBIO)
BridgeBio Pharma, Inc. (BBIO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $904.03 M.
Top institutional holders include Andreas Halvorsen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bearish. This is evidenced by a $144.24 M net outflow during the quarter.
Recent activity highlights Ray Dalio who increased their stake by 501.0%. Conversely, Jefferies Group reduced exposure by 58.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for BridgeBio Pharma, Inc. (BBIO)
Major holders include Andreas Halvorsen ($879.42 M), Renaissance Technologies (RenTech) ($27.16 M), Ken Fisher ($26.11 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 13.29 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $144.24 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited BBIO. The total reported sell value was $198.21 M.
Yes, 1 managers opened new positions in BBIO, and 3 increased their existing holdings. The total reported buy value was $53.98 M.
